These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7196886)
1. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978. Browne SG; Harman DJ; Waudby H; McDougall AC Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886 [TBL] [Abstract][Full Text] [Related]
2. Spaced clofazimine therapy of lepromatous leprosy. Am J Trop Med Hyg; 1976 May; 25(3):437-44. PubMed ID: 779502 [TBL] [Abstract][Full Text] [Related]
3. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy. Rodriguez JN; Abalos RM; Reich CV; Tolentino JG Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715 [No Abstract] [Full Text] [Related]
4. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720 [No Abstract] [Full Text] [Related]
5. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
7. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases. Sharma PK; Singh DK Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954 [TBL] [Abstract][Full Text] [Related]
8. Effect of three-year multidrug therapy in multibacillary leprosy patients. Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263 [TBL] [Abstract][Full Text] [Related]
9. The antileprotic action of clofazimine (B663, G30, 320, Lamprene). Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163 [No Abstract] [Full Text] [Related]
10. Transformation from lepromatous to borderline leprosy under clofazimine therapy. Mahapatra SB; Ramu G Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964 [TBL] [Abstract][Full Text] [Related]
16. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine. Ramu G; Girdhar A Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases. Kundu SK; Hazra SK; Chaudhury S; Chatterjee B Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for erythema nodosum leprosum. Manandhar R; LeMaster JW; Roche PW Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [TBL] [Abstract][Full Text] [Related]
19. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy. Paul S; Rose ET Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625 [No Abstract] [Full Text] [Related]
20. A comparative evaluation of levamisole in leprosy. Sharma L; Thalliath GH; Girgia HS; Sen PC Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]